QSIAW
Closed
Quantum-si Incorporated
0.7048
0.0000 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.7048
Day's Range: 0.6301 - 0.7049
Send
sign up or login to leave a comment!
When Written:
0.1527
Quantum-Si is a biotech company that is focused on developing and commercializing a new class of protein sequencing technology that can revolutionize the field of precision medicine. The company was founded in 2015 by Dr. Jonathan Rothberg, a renowned entrepreneur and inventor who has pioneered several breakthroughs in DNA sequencing technology.
Quantum-Si's technology is based on a proprietary platform that uses single-molecule fluorescence imaging to detect and sequence proteins with high accuracy and throughput. This technology has the potential to enable a wide range of applications in diagnostics, drug discovery, and personalized medicine.
The company has raised over $200 million in funding from leading investors, including Venrock, Khosla Ventures, and Sequoia Capital. It has also formed strategic partnerships with several major pharmaceutical companies, including Bristol Myers Squibb and Biogen, to develop new therapies and diagnostics based on its protein sequencing technology.
Quantum-Si is headquartered in San Francisco, California, and has a team of over 200 scientists, engineers, and business professionals. The company is committed to advancing the field of precision medicine and improving patient outcomes through its innovative technology and collaborative approach to research and development.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Quantum-Si's technology is based on a proprietary platform that uses single-molecule fluorescence imaging to detect and sequence proteins with high accuracy and throughput. This technology has the potential to enable a wide range of applications in diagnostics, drug discovery, and personalized medicine.
The company has raised over $200 million in funding from leading investors, including Venrock, Khosla Ventures, and Sequoia Capital. It has also formed strategic partnerships with several major pharmaceutical companies, including Bristol Myers Squibb and Biogen, to develop new therapies and diagnostics based on its protein sequencing technology.
Quantum-Si is headquartered in San Francisco, California, and has a team of over 200 scientists, engineers, and business professionals. The company is committed to advancing the field of precision medicine and improving patient outcomes through its innovative technology and collaborative approach to research and development.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!